XML 33 R9.htm IDEA: XBRL DOCUMENT v3.20.4
Marketable Securities
 12 Months Ended
Dec. 31, 2020
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities Marketable Securities
Available-for-sale marketable securities as of December 31, 2020 and 2019 were as follows (in thousands):
December 31, 2020
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
U.S. Treasury securities$60,630 $1 $(7)$60,624 
Corporate debt securities30,777 2 (3)30,776 
Total$91,407 $3 $(10)$91,400 

December 31, 2019
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Government-sponsored enterprises$13,216 $6 $— $13,222 
Corporate debt securities76,052 20 (10)76,062 
Total$89,268 $26 $(10)$89,284 
All of the Company's available-for-sale securities held at December 31, 2020 and 2019 had contractual maturities of less than one year. All of the Company’s available-for-sale marketable debt securities in an unrealized loss position as of December 31, 2020 and 2019 were in a loss position for less than twelve months.  Unrealized losses on available-for-sale debt securities as of December 31, 2020 were not significant and were primarily due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, no allowance for credit losses related to the Company's available-for-sale debt securities was recorded for the year ended December 31, 2020. The Company does not intend to sell these investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity. No losses related to other-than-temporary impairments of the Company’s available-for-sale debt securities were recorded in Accumulated other comprehensive income during the year ended December 31, 2019. The Company recorded interest income of $0.8 million, $3.4 million and $2.3 million during the years ended December 31, 2020, 2019 and 2018, respectively, which is included in Other income (expense) on the consolidated statements of operations and comprehensive loss.